Preoperative systemic immune-inflammation index for predicting the prognosis of thymoma with radical resection
- PMID: 36951114
- PMCID: PMC10151138
- DOI: 10.1111/1759-7714.14854
Preoperative systemic immune-inflammation index for predicting the prognosis of thymoma with radical resection
Abstract
Background: To investigate the clinical significance of preoperative systemic immune-inflammation index (SII) in patients with thymoma who underwent radical resection.
Methods: This retrospective study involved 425 patients with thymoma who underwent radical resection at the First Affiliated Hospital of Nanjing Medical University between September 1, 2008 and December 30, 2019. Data regarding routine preoperative blood tests and clinical features were collected to calculate and analyze the SII, platelet-to-lymphocyte ratio (PLR), and neutrophil-to-lymphocyte ratio (NLR).
Results: Univariate analysis indicated that age (p = 0.021), tumor size (p = 0.003), extended resection (p < 0.001), Masaoka-Koga stage (p < 0.001), PLR (p = 0.012), NLR (p = 0.041), and SII (p = 0.003) were related to patient prognosis. A higher SII (>345.83) was a significant independent prognostic factor in this cohort (p = 0.001, HR = 5.756, 95% CI: 2.144-15.457). Multivariate analysis showed that a high PLR was significantly associated with overall survival (OS) (p = 0.008, HR = 3.29, 95% CI: 1.371-7.896), while a high NLR was a significant independent prognostic factor for shorter OS (p = 0.024, HR = 2.654, 95% CI: 1.138-6.19). SII had an area under the curve (AUC) of 70.6% (AUC = 0.706) exceeding the predictive value for PLR (AUC = 0.678) and NLR (AUC = 0.654).
Conclusion: Preoperative SII can predict the prognosis of thymoma patients who have undergone radical resection but further multicenter prospective studies are needed to investigate the role of SII in thymoma.
Keywords: NLR; PLR; SII; prognosis; thymoma.
© 2023 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd.
Conflict of interest statement
The authors have no conflicts of interest to declare.
Figures





Similar articles
-
[Relationship between preoperative inflammatory indexes and prognosis of patients with rectal cancer and establishment of prognostic nomogram prediction model].Zhonghua Zhong Liu Za Zhi. 2022 May 23;44(5):402-409. doi: 10.3760/cma.j.cn112152-20200630-00612. Zhonghua Zhong Liu Za Zhi. 2022. PMID: 35615796 Chinese.
-
[The prognostic value of preoperative peripheral blood inflammatory biomarkers for intrahepatic cholangiocarcinoma after radical resection].Zhonghua Zhong Liu Za Zhi. 2022 Nov 23;44(11):1194-1201. doi: 10.3760/cma.j.cn112152-20210324-00265. Zhonghua Zhong Liu Za Zhi. 2022. PMID: 36380668 Chinese.
-
The Relationship Between Preoperative Systemic Immune Inflammation Index and Prognostic Nutritional Index and the Prognosis of Patients With Alveolar Hydatid Disease.Front Immunol. 2021 Jun 24;12:691364. doi: 10.3389/fimmu.2021.691364. eCollection 2021. Front Immunol. 2021. PMID: 34248983 Free PMC article.
-
Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab.J Clin Lab Anal. 2019 Oct;33(8):e22964. doi: 10.1002/jcla.22964. Epub 2019 Jul 8. J Clin Lab Anal. 2019. PMID: 31282096 Free PMC article.
-
Prognostic value of preoperative hematological markers in patients with glioblastoma multiforme and construction of random survival forest model.BMC Cancer. 2023 May 12;23(1):432. doi: 10.1186/s12885-023-10889-0. BMC Cancer. 2023. PMID: 37173662 Free PMC article.
Cited by
-
Prognostic significance of systemic immune-inflammation index in patients with ovarian cancer: a meta-analysis.Front Oncol. 2023 Jun 5;13:1193962. doi: 10.3389/fonc.2023.1193962. eCollection 2023. Front Oncol. 2023. PMID: 37342198 Free PMC article.
-
Effects of intravenous anesthesia and inhalation anesthesia on postoperative inflammatory markers in patients with esophageal cancer: a retrospective study.BMC Anesthesiol. 2024 Dec 19;24(1):462. doi: 10.1186/s12871-024-02856-4. BMC Anesthesiol. 2024. PMID: 39695976 Free PMC article.
-
Prognostic role of C-reactive protein in patients with endometrial cancer: a meta-analysis.Biomark Med. 2024;18(6):279-289. doi: 10.2217/bmm-2023-0810. Epub 2024 Apr 19. Biomark Med. 2024. PMID: 38639733 Free PMC article. Review.
-
Prognostic value of pretreatment lymphocyte-to-monocyte ratio in patients with glioma: a meta-analysis.BMC Med. 2023 Dec 5;21(1):486. doi: 10.1186/s12916-023-03199-6. BMC Med. 2023. PMID: 38053096 Free PMC article.
-
Prognostic and clinicopathological impacts of systemic immune-inflammation index on patients with diffuse large B-cell lymphoma: a meta-analysis.Ther Adv Hematol. 2023 Nov 10;14:20406207231208973. doi: 10.1177/20406207231208973. eCollection 2023. Ther Adv Hematol. 2023. PMID: 37954483 Free PMC article.
References
-
- He J, Wei W. China cancer registration annual report 2019: People's Medical Publishing House (PMPH). 2020.
-
- Scorsetti M, Leo F, Trama A, D'Angelillo R, Serpico D, Macerelli M, et al. Thymoma and thymic carcinomas. Crit Rev Oncol Hematol. 2016;99:332–50. - PubMed
-
- Ettinger DS, Riely GJ, Akerley W, Borghaei H, Chang AC, Cheney RT, et al. Thymomas and thymic carcinomas: clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2013;11(5):562–76. - PubMed
-
- Marom EM. Imaging thymoma. J Thorac Oncol. 2010;5(10 Suppl 4):S296–303. - PubMed
-
- Masaoka A. Staging system of thymoma. J Thorac Oncol. 2010;5(10 Suppl 4):S304–12. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical